A generic scale cannot differentiate between fluid retention and tissue loss
Back Marso, SP, Daniels, GH, Brown-Frandsen, K, et al (28 July 2016) 'Liraglutide and cardiovascular outcomes in type 2 diabetes', New England Journal of Medicine , 375/4, 311-22
While lower than injectable averages, it is still clinically meaningful
Here's an honest look at how they compare on results, side effects, and cost, backed by FDA and NIH sources
Gallwitz B, Vaag A, Falahati A, Madsbad S
GLP-1 albumin fusions stimulate insulin secretion through a GLP-1R-dependent mechanism To test the ability of the GLP-1 albumin fusions to activate the GLP-1R in vitro, we used a human GLP-1R reporter cell assay kit, where serial dilutions of unfused GLP-1, GLP-1 WT, or GLP-1 QMP were incubated with the cells overnight (Fig